AOBiome: AOB Pharma, Maruho partner to develop B244 for inflammatory ailments

B244, which is presently being readied for international Phase III clinical trials, is a therapeutic treatment aimed at inflammatory indications such as atopic dermatitis, addressing both appearance and The post AOB Pharma, Maruho partner to develop B244 for inflammatory ailments appeared first on Pharmaceutical Business review.